Tuesday, February 17, 2015 2:05:02 PM
And yes - that does seem to be the MO for the FDA,.... err always on the side of caution.
Don't get me wrong - I would rather have the FDA there to act as an arbitrator / monitor of proposed treatments than not - but they do often seem to be as much a barrier to progress as a shepherd for good drugs/treatments.
Have only been watching HEB since I first heard about the successful tests against Ebola back last November, and have only been a shareholder here since the day after announcing the mouse efficacy test results (the day price shot back down - lucky for me),.... and am still in the learning & DD phase here with my first vested stake.
Will be looking to add shares as cash becomes available, and assuming that further progress is made by HEB.
And - in the long run - anything that might have a positive effect on people suffering from CFS (have a friend of my wife's family who has been dealing with it for a decade or more) is probably going to be beneficial for patients, and profitable for me.
“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM